As­traZeneca chair­man re­peats their po­si­tion on in­vest­ing in UK dur­ing Brex­it talks, trig­ger­ing fresh fears

LON­DON — With a loom­ing ex­it from the EU com­ing up, it’s not hard for any com­pa­ny to spur in­tense anx­i­ety in the UK …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.